Prescribing information infusion
Found 7 free book(s)
HIGHLIGHTS OF PRESCRIBING INFORMATION - Genentech
www.gene.com2 FULL PRESCRIBING INFORMATION WARNING: CARDIOMYOPATHY, INFUSION REACTIONS, EMBRYO-FETAL TOXICITY, and PULMONARY TOXICITY Cardiomyopathy Herceptin administration can …
HIGHLIGHTS OF PRESCRIBING INFORMATION The dose for …
www.gene.comfull prescribing information warning: fatal infusion reactions, severe mucocutaneous reactions, hepatitis b virus reactivation and progressive
HIGHLIGHTS OF PRESCRIBING INFORMATION - BMS
packageinserts.bms.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use YERVOY safely and effectively. See full prescribing information for YERVOY.
HIGHLIGHTS OF PRESCRIBING INFORMATION immune …
www.regeneron.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LIBTAYO safely and effectively. See full prescribing information for LIBTAYO.
HIGHLIGHTS OF PRESCRIBING INFORMATION DOSAGE ... - …
www.venofer.comFULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE Venofer is indicated for the treatment of iron deficiency anemia in patients with chronic kidney disease (CKD).
HIGHLIGHTS OF PRESCRIBING INFORMATION - BMS
packageinserts.bms.comFULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Unresectable or Metastatic Melanoma • OPDIVO® (nivolumab) as a single agent is indicated for the treatment of patients with BRAF V600 wild-type unresectable or metastatic melanoma [see Clinical Studies (14.1)].
WARNING: CAPILLARY LEAK SYNDROME See full prescribing ...
elzonris.com2 . FULL PRESCRIBING INFORMATION . 1 INDICATIONS AND USAGE . ELZONRIS is a CD123-directed cytotoxin for the treatment of blastic plasmacytoid dendritic cell neoplasm